Paediatric pulmonary actinomycosis: A forgotten disease

Area of Science:

• Infectious Diseases
• Pulmonology
• Microbiology

Background:

• Actinomycosis is a rare, invasive bacterial infection caused by Actinomyces species, characterized by indolent progression and potential systemic spread.
• The infection typically arises from mucosal barrier disruption, leading to endogenous spread and involvement of various organs, most commonly cervicofacial, abdominopelvic, and thoracic soft tissues.
• Pulmonary actinomycosis, though rare, particularly in young children, presents with nonspecific chest x-ray findings that can mimic other conditions like tuberculosis or malignancy.

Purpose of the Study:

• To review the clinical presentation, diagnostic challenges, and treatment of pulmonary actinomycosis.
• To highlight the importance of recognizing characteristic findings in bronchoalveolar lavage fluid and the susceptibility of Actinomyces to specific antibiotics.
• To emphasize the need for early diagnosis and prolonged antibiotic therapy for favorable outcomes.

Main Methods:

• Review of clinical findings, imaging characteristics (chest x-ray), and diagnostic methods including endobronchial biopsy and bronchoalveolar lavage cytology.
• Analysis of microbiological characteristics, specifically the identification of sulfur granules and Gram-positive filamentous bacilli.
• Evaluation of treatment strategies, focusing on antibiotic susceptibility and duration of therapy.

Main Results:

• Pulmonary actinomycosis presents with varied symptoms including chest wall mass, cough, pain, weight loss, fever, draining sinuses, and hemoptysis.
• Chest x-ray findings are often nonspecific, requiring careful differentiation from other pulmonary diseases.
• Bronchoalveolar lavage cytology may reveal sulfur granules and Gram-positive filamentous bacilli suggestive of Actinomycosis.
• Actinomyces species demonstrate high susceptibility to beta-lactam antibiotics, particularly penicillin G and amoxicillin.

Conclusions:

• Pulmonary actinomycosis requires a high index of suspicion due to its nonspecific presentation and overlapping radiographic features with other conditions.
• Diagnostic confirmation relies on identifying characteristic microbiological findings, such as sulfur granules and specific bacterial morphology.
• Effective treatment involves prolonged administration of beta-lactam antibiotics, with treatment durations potentially extending up to 20 months.
• Early diagnosis and appropriate, extended antibiotic treatment are crucial for achieving a good prognosis and low mortality in pulmonary actinomycosis.